Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Drug Discovery Today|December 9, 2023
Medicinal chemistry aspects of uracil containing dUTPase inhibitors targeting colorectal cancerNabeel Backer, Adarsh Kumar, Ankit Kumar Singh, et al.
Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan|May 20, 2024
A comprehensive review on pharmacognosy, phytochemistry and pharmacological activities of 8 potent species of southeast AsiaShikha Agrawal, Adarsh Kumar, Ankit Kumar Singh, et al.
Veterinary World|June 17, 2017
Isolation, morphological identification and <i>in vitro</i> antibacterial activity of endophytic bacteria isolated from <i>Azadirachta indica</i> (neem) leavesAnkit Kumar Singh, Rajesh Kumar Sharma, Varsha Sharma, et al.
Nanoscale|August 15, 2023
Dielectric metasurface-assisted cavity ring-down spectroscopy for thin-film circular dichroism analysisAnkit Kumar Singh, Zhan-Hong Lin, Min Jiang, et al.
Annals of Surgical Oncology|May 17, 2024
Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic TargetsVipendra Kumar Singh, Naina Rajak, Yashasvi Singh, et al.
Chemistry & Biodiversity|July 26, 2024
Ethnomedicinal Uses, Phytochemistry, Pharmacology, and Toxicology of Ruellia tuberosa L.: A ReviewAkanksha Sharma, Adarsh Kumar, Ankit Kumar Singh, et al.
Chemistry & Biodiversity|August 4, 2023
Phytochemical Profiling and Pharmacological Evaluation of Leaf Extracts of Ruellia tuberosa L.: An In Vitro and In Silico ApproachAkanksha Sharma, Adarsh Kumar, Ankit Kumar Singh, et al.
Chemistry & Biodiversity|March 6, 2026
Unrevealing the Multifaceted Role of Resveratrol as Potential Antioxidant and Anticancer Agent: Molecular Mechanism and Future PerspectivesArvind Sharma, Adarsh Kumar, Ravi P Chaudhary, et al.
The Review of Scientific Instruments|April 3, 2016
Experimental investigation of defect-assisted and intrinsic water vapor permeation through ultrabarrier filmsHyungchul Kim, Ankit Kumar Singh, Cheng-Yin Wang, et al.
Expert Opinion on Therapeutic Patents|October 14, 2025
Medicinal chemistry perspective of ERK1/2 inhibitors in cancer treatment: an updated patent review (2019-present)Ankit Kumar Singh, Ajad Chauhan, Vineet Prajapati, et al.
Pageof 9